Fernanda Carvalho Poyraz

Fernanda Carvalho Poyraz

Auto-generated profile, based on publicly available information

Fernanda Carvalho Poyraz

Department of Neurology (F.C.P., M.R., M.S., A.K., S.G., S.A., S.P., J.C., D.J.R.), Vagelos College of Physicians and Surgeons, Columbia University, New York

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Neuron
Verified
Journal Article
Closed access
MCMaxime Cazorla
Maxime Cazorla
FCFernanda Delmondes de Carvalho
Fernanda Delmondes de Carvalho
MCMuhammad O. Chohan
Muhammad O. Chohan
MSMariya Shegda
Mariya Shegda
NCNao Chuhma
Nao Chuhma
CKChristoph Kellendonk
Christoph Kellendonk

20 June 2010 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
DCDerek P Claxton
Derek P Claxton
MQMatthias Quick
Matthias Quick
LSLei Shi
Lei Shi
FCFernanda Delmondes de Carvalho
Fernanda Delmondes de Carvalho
HWHarel Weinstein
Harel Weinstein
HMHassane S Mchaourab
Hassane S Mchaourab
LeuT is a bacterial sodium/leucine symporter, related to human neurotransmitters targeted by antidepressant drugs. Now spin labeling and EPR analysis on the dynamics in the extracellular vestibule of LeuT reveal the conformational changes caused by Na+ and Leu binding that drive the transport cycle. Crystallographic, computational and functional analyses of LeuT have revealed details of the molecular architecture of Na+-coupled transporters and the mechanistic nature of ion/substrate coupling, but the conformational changes that support a functional transport cycle have yet to be described fully. We have used site-directed spin labeling and electron paramagnetic resonance (EPR) analysis to capture the dynamics of LeuT in the region of the extracellular vestibule associated with the binding of Na+ and leucine. The results outline the Na+-dependent formation of a dynamic outward-facing intermediate that exposes the primary substrate binding site and the conformational changes that occlude this binding site upon subsequent binding of the leucine substrate. Furthermore, the binding of the transport inhibitors tryptophan, clomipramine and octyl-glucoside is shown to induce structural changes that distinguish the resulting inhibited conformation from the Na+/leucine-bound state.

1 June 2016 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
FPFernanda Carvalho Poyraz
Fernanda Carvalho Poyraz
EHEva Holzner
Eva Holzner
MBMatthew R. Bailey
Matthew R. Bailey
JMJozsef Meszaros
Jozsef Meszaros
LKLindsay Kenney
Lindsay Kenney
CKChristoph Kellendonk
Christoph Kellendonk
Altered dopamine D2 receptor (D2R) binding in the striatum has been associated with abnormal motivation in neuropsychiatric disorders, including schizophrenia. Here, we tested whether motivational deficits observed in mice with upregulated D2Rs (D2R-OEdevmice) are reversed by decreasing function of the striatopallidal “no-go” pathway. To this end, we expressed the Gαi-coupled designer receptor hM4D in adult striatopallidal neurons and activated the receptor with clozapine-N-oxide (CNO). Using a head-mounted miniature microscope we confirmed with calcium imaging in awake mice that hM4D activation by CNO inhibits striatopallidal function measured as disinhibited downstream activity in the globus pallidus. Mice were then tested in three operant tasks that address motivated behavior, the progressive ratio task, the progressive hold-down task, and outcome devaluation. Decreasing striatopallidal function in the dorsomedial striatum or nucleus accumbens core enhanced motivation in D2R-OEdevmice and control littermates. This effect was due to increased response initiation but came at the cost of goal-directed efficiency. Moreover, response vigor and the sensitivity to changes in reward value were not altered. Chronic activation of hM4D by administering CNO for 2 weeks in drinking water did not affect motivation due to a tolerance effect. However, the acute effect of CNO on motivation was reinstated after discontinuing chronic treatment for 48 h. Used as a therapeutic approach, striatopallidal inhibition should consider the risk of impairing goal-directed efficiency and behavioral desensitization.SIGNIFICANCE STATEMENTMotivation involves a directional component that allows subjects to efficiently select the behavior that will lead to an optimal outcome and an activational component that initiates and maintains the vigor and persistence of actions. Striatal output pathways modulate motivated behavior, but it remains unknown how these pathways regulate specific components of motivation. Here, we found that the indirect pathway controls response initiation without affecting response vigor or the sensitivity to changes in the reward outcome. A specific enhancement in the activational component of motivation, however, can come at the cost of goal-directed efficiency when a sustained response is required to obtain the goal. These data should inform treatment strategies for brain disorders with impaired motivation such as schizophrenia and Parkinson's disease.

1 January 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
FCFernanda Delmondes de Carvalho
Fernanda Delmondes de Carvalho
MQMatthias Quick
Matthias Quick
Iodide (I(-)) is an essential constituent of the thyroid hormones triiodothyronine and thyroxine, which are required for the development of the central nervous system in the fetus and newborn. I(-) uptake in the thyroid is mediated by the Na(+)/I(-) symporter (NIS). NIS has gained particular medical interest due to its sensitivity to the environmental pollutant perchlorate (ClO(4)(-)) and its implication in radioiodide cancer treatment. Recently, others have shown that I(-) absorption in the intestine is mediated by NIS (Nicola, J. P., Basquin, C., Portulano, C., Reyna-Neyra, A., Paroder, M., and Carrasco, N. (2009) Am. J. Physiol. Cell Physiol. 296, C654-662). However, their data suggest the participation of other systems in the homeostasis of I(-), in particular because in vivo uptake studies revealed a ClO(4)(-)-insensitive transport component. Here, we describe Na(+)-coupled I(-) uptake by the human Na(+)/multivitamin transporter (hSMVT), a related protein isolated from the placenta, where it was suggested to supply the fetus with the water-soluble vitamins biotin and pantothenic acid, and α-lipoic acid. hSMVT-mediated Na(+)/I(-) symport is inhibited by the other three organic hSMVT substrates but not by NIS substrates; notably, hSMVT is insensitive to ClO(4)(-). Because hSMVT is found in the intestine and in many other tissues, we propose that hSMVT may play an important role in the homeostasis of I(-) in the body.

1 May 2016 in Neuroscience
Verified
Journal Article
Closed access
SBS.S. Bolkan
S.S. Bolkan
FPF. Carvalho Poyraz
F. Carvalho Poyraz
CKC. Kellendonk
C. Kellendonk

1 April 2023 in Stroke
Verified
Journal Article
Closed access
DRDavid J. Roh
David J. Roh
ABAmelia Boehme
Amelia Boehme
RMRayan Mamoon
Rayan Mamoon
DHDestiny Hooper
Destiny Hooper
ACAzzurra Cottarelli
Azzurra Cottarelli
DWDaniel Woo
Daniel Woo
Background: Hemoglobin concentration and diffusion-weighted imaging (DWI) ischemic lesions are separately known to be associated with poor intracerebral hemorrhage (ICH) outcomes. While hemoglobin concentrations have known relationships with ischemic stroke, it is unclear whether hemoglobin concentration is associated with DWI ischemic lesions after ICH. We sought to investigate the hypothesis that hemoglobin concentrations would associate with DWI lesions after ICH and further investigated their relationships with clinical outcomes. Methods: Supratentorial ICH patients enrolled between 2010 and 2016 to a prospective, multicenter, observational cohort study (ERICH study [Ethnic/Racial Variations of Intracerebral Hemorrhage]) were assessed. Patients from this study with baseline, admission hemoglobin, and hospitalization magnetic resonance imaging were analyzed. Hemoglobin was examined as the primary exposure variable defined as a continuous variable (g/dL). Magnetic resonance imaging DWI ischemic lesion presence was assessed as the primary radiographic outcome. Primary analyses assessed relationships of hemoglobin with DWI lesions. Secondary analyses assessed relationships of DWI lesions with poor 3-month outcomes (modified Rankin Scale score, 4–6). These analyses were performed using separate multivariable logistic regression models adjusting for relevant covariates. Results: Of 917 patients with ICH analyzed, mean baseline hemoglobin was 13.8 g/dL (±1.9), 60% were deep ICH, and DWI lesions were identified in 27% of the cohort. In our primary analyses, increased hemoglobin, defined as a continuous variable, was associated with DWI lesions (adjusted odds ratio, 1.21 per 1 g/dL change in hemoglobin [95% CI, 1.07–1.37]) after adjusting for sex, race, ICH severity, time to magnetic resonance imaging, and acute blood pressure change. In secondary analyses, DWI lesions were associated with poor 3-month outcomes (adjusted odds ratio, 1.83 [95% CI, 1.24–2.69]) after adjusting for similar covariates. Conclusions: We identified novel relationships between higher baseline hemoglobin concentrations and DWI ischemic lesions in patients with ICH. Further studies are required to clarify the role of hemoglobin concentration on both cerebral small vessel disease pathophysiology and ICH outcomes.